Search

Your search keyword '"Sarra Smati"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Sarra Smati" Remove constraint Author: "Sarra Smati"
49 results on '"Sarra Smati"'

Search Results

1. The pregnane X receptor drives sexually dimorphic hepatic changes in lipid and xenobiotic metabolism in response to gut microbiota in mice

2. Selective Liver Estrogen Receptor α Modulation Prevents Steatosis, Diabetes, and Obesity Through the Anorectic Growth Differentiation Factor 15 Hepatokine in Mice

Catalog

Books, media, physical & digital resources

3. Endoplasmic reticulum stress controls iron metabolism through TMPRSS6 repression and hepcidin mRNA stabilization by RNA-binding protein HuR

4. Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: The IT-DIAB study.

6. Obesity promotes fumonisin B1 hepatotoxicity

7. Obesity promotes Fumonisin B1 toxicity and induces hepatitis

8. COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO Study

9. History of bariatric surgery and COVID-19 outcomes in patients with type 2 diabetes: Results from the CORONADO study

10. Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative

11. Anti-diabetic drugs and NASH: from current options to promising perspectives

12. Pituitary adenoma in patients with multiple endocrine neoplasia type 1: a cohort study

13. Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study

14. Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target

15. The pregnane X receptor drives sexually dimorphic hepatic changes in lipid and xenobiotic metabolism in response to gut microbiota in mice

16. ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARα activity

17. Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study

18. The hepatocyte insulin receptor is required to program rhythmic gene expression and the liver clock

19. ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARα activity

20. The hepatocyte insulin receptor is required to program the liver clock and rhythmic gene expression

21. Additional file 14 of The pregnane X receptor drives sexually dimorphic hepatic changes in lipid and xenobiotic metabolism in response to gut microbiota in mice

22. Additional file 3 of The pregnane X receptor drives sexually dimorphic hepatic changes in lipid and xenobiotic metabolism in response to gut microbiota in mice

23. Additional file 8 of The pregnane X receptor drives sexually dimorphic hepatic changes in lipid and xenobiotic metabolism in response to gut microbiota in mice

24. Additional file 5 of The pregnane X receptor drives sexually dimorphic hepatic changes in lipid and xenobiotic metabolism in response to gut microbiota in mice

25. Genetic Inhibition of PCSK9 and Liver Function

26. Author response for 'Relationship between obesity and severe <scp>COVID</scp> ‐19 outcomes in patients with type 2 diabetes: results from the <scp>CORONADO</scp> study'

27. Author Correction: Dimorphic metabolic and endocrine disorders in mice lacking the constitutive androstane receptor

28. Awareness of chronic liver diseases, a comparison between diabetologists and general practitioners

29. Expert opinion on the metabolic complications of mTOR inhibitors

30. Expert opinion on immunotherapy induced diabetes

31. Regulation of hepatokine gene expression in response to fasting and feeding: Influence of PPARa and insulin-dependent signaling in hepatocytes

32. Relationship between obesity and severe COVID ‐19 outcomes in patients with type 2 diabetes: Results from the CORONADO study

33. Gene Expression Profiling Reveals that PXR Activation Inhibits Hepatic PPARα Activity and Decreases FGF21 Secretion in Male C57Bl6/J Mice

34. Gene Expression Profiling Reveals That PXR Activation Inhibits Hepatic PPARα Activity and Decreases FGF21 Secretion in Male C57Bl6/J Mice

35. Hepatic PPARα is critical in the metabolic adaptation to sepsis

36. Euglycaemic ketoacidosis during gestational diabetes with concomitant COVID-19 infection

37. Hepatocyte-specific deletion of Pparα promotes NASH in the context of obesity

38. [LDL-cholesterol hypothesis:the lower is trully better]

39. Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population

40. Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions

41. French Endocrine Society Guidance on endocrine side effects of immunotherapy

42. Expert opinion on the metabolic complications of new anticancer therapies: Tyrosine kinase inhibitors

43. The protective role of liver X receptor (LXR) during fumonisin B1-induced hepatotoxicity

44. Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation

45. Insights into the role of hepatocyte PPARα activity in response to fasting

46. Influence du genre dans la sensibilité à la stéatose et de la stéato-hépatite non alcoolique

47. Mosaicism in HIF2A-related polycythemia-paraganglioma syndrome

48. CA-167: Impact des statines sur le risque de diabète de type 2 (DT2) chez des sujets prédiabétiques : résultats de l'étude prospective IT-DIAB